- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/08 - Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigoAntiemetics
Patent holdings for IPC class A61P 1/08
Total number of patents in this class: 535
10-year publication summary
|
18
|
21
|
31
|
35
|
44
|
37
|
35
|
28
|
33
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2719 |
21 |
| Acacia Pharma Limited | 41 |
17 |
| Helsinn Healthcare SA | 227 |
15 |
| Vanda Pharmaceuticals, Inc. | 382 |
11 |
| Cindome Pharma, Inc. | 18 |
9 |
| Altria Client Services LLC | 2353 |
8 |
| Duchesnay Inc. | 65 |
7 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1344 |
7 |
| Starton Therapeutics, Inc. | 25 |
6 |
| Evoke Pharma, Inc. | 30 |
5 |
| Kissei Pharmaceutical Co., Ltd. | 176 |
5 |
| Shionogi & Co., Ltd. | 864 |
5 |
| Hoffmann-La Roche Inc. | 3679 |
4 |
| Pfizer Inc. | 3362 |
4 |
| Adimab, LLC | 148 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 694 |
4 |
| Lankenau Institute for Medical Research | 100 |
4 |
| LTS Lohmann Therapie-Systeme AG | 686 |
4 |
| Neurogastrx, Inc. | 19 |
4 |
| Raqualia Pharma Inc. | 122 |
4 |
| Other owners | 387 |